[CLOSED] Public consultation of the adapted methodological guideline “Endpoints used in Relative Effectiveness Assessment – Safety”
We are pleased to announce that as of today, 21 October, 2015, the methodological guideline “Endpoints used in Relative Effectiveness Assessment – Safety”, originally published in March 2013 and now adapted within WP7 – Subgroup 3, has entered the public consultation phase. This consultation will take place between 21 October and 17 November 2015. Objective […]
[CLOSED] Public consultation of Draft Assessment Report of the sixth pilot of WP5 Strand A: Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C
We are pleased to announce that as of today, 15 October, the Second Draft Report focusing on the production of a Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C by Work Package 5, Strand A has entered the public consultation phase. This consultation phase will take place between 15 […]
[CLOSED] Public consultation of the draft methodological guideline “Therapeutic medical devices”
We are pleased to announce that as of today, 14 October, 2015, the draft methodological guideline “Therapeutic medical devices”, produced within WP7 – Subgroup 3, has entered the public consultation phase. This consultation will take place between 14 October and 11 November 2015. Objective of the methodological guideline EUnetHTA´s methodological guidelines are targeted to the […]
[CLOSED] Public and internal consultation of eight adapted methodological guidelines for Relative Effectiveness Assessment (REA)
We are pleased to announce that the eight adapted methodological guidelines for Relative Effectiveness Assessment (REA) developed in JA1 and revised by WP7 – Subgroup 3 in JA2, are ready for public consultation.. The consultation will take place between 26 August and 9 October 2015. Aim and method of guidelines´ revision According to the Grant […]
[CLOSED] Public consultation on the HTA Core Model for rapid Relative Effectiveness Assessments
We are pleased to announce that as of today the HTA Core Model for rapid Relative Effectiveness Assessments, by Work Package 5, has entered the public consultation phase. This consultation phase will take place between 28 July and 4 September 2015. Objective of the HTA Core Model for rapid REAs The HTA Core Model is […]
[CLOSED] Public consultation of the Draft Project Plan on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke”
We are pleased to announce that as of today the Draft Project Plan “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke”, produced within WP5 Strand B, has entered the public consultation phase. This consultation will take place between 10/06 and 29/06/2015. Objective of Draft Project Plan The aim of the Draft Project Plan […]
[CLOSED] Public consultation on “the use of Intravenous immunoglobulins for Alzheimer’s disease including Mild Cognitive Impairment”
We are happy to announce that the second Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Use of Intravenous immunoglobulins for Alzheimer’s disease including Mild Cognitive Impairment” This consultation will take place between June 18th and July 15th, 2015. Objective of public […]
[CLOSED] Public consultation on the position paper on how to decide on the appropriate study design for primary research arising from HTA
In order to gather as much feedback as possible, WP7 Subgroup 2 has decided to extend the public consultation period on the Position paper on how to decide on the appropriate study design until May 29, 2015 at 12:00 noon CET. Objective of the position paper This document is one of two WP7 SG2 methodological […]
[CLOSED] Public consultation on the Position paper on how to best formulate research recommendations for primary research arising from HTA reports.
Deadline extended – Public consultation on the Position paper on how to best formulate research recommendations for primary research arising from HTA reports. In order to gather as much feedback as possible, WP7 Subgroup 2 has decided to extend the public consultation period on the position paper on how to best formulate research recommendations until June […]
[CLOSED] Public consultation of the draft methodological guideline “Internal validity of non-randomised studies (NRS) on interventions”
We are pleased to announce that as of today, 20 April, 2015, the draft methodological guideline “Internal validity of non-randomised studies (NRS) on interventions”, produced within WP7 – Subgroup 3, has entered the public consultation phase. This consultation will take place between 20 April and 15 May 2015. Objective of the methodological guideline EUnetHTA´s methodological […]